Steroidogenesis in human aldosterone-secreting adenomas and adrenal hyperplasias: Effects of hypoxia in vitro

American Journal of Physiology - Endocrinology and Metabolism

Volumn 290, Issue 1, 2006, Pages

  Raff, Hershel ^a,b   Bruder, Eric D ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b St Luke's Physician's Office Building   (United States)

Author keywords

Adrenal cortex; Cortisol; Dehydroepiandrosterone; Oxygen

Indexed keywords

ALDOSTERONE; CORTICOTROPIN; CYCLIC AMP; HYDROCORTISONE; PRASTERONE; OXYGEN; STEROID;

ADRENAL CORTEX ADENOMA; ADRENAL GLAND; ADRENAL HYPERPLASIA; ALDOSTERONE RELEASE; ARTICLE; CONTROLLED STUDY; CUSHING SYNDROME; HISTOPATHOLOGY; HORMONE RESPONSE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPEROXIA; HYPOXIA; IN VITRO STUDY; OXYGEN TENSION; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; STEROIDOGENESIS; BIOSYNTHESIS; CELL CULTURE; CELL HYPOXIA; DRUG EFFECT; HYPERPLASIA; METABOLISM; PATHOLOGY; PRESSURE; SECRETION;

ADRENAL GLANDS; ADRENOCORTICAL ADENOMA; ADRENOCORTICOTROPIC HORMONE; ALDOSTERONE; CELL HYPOXIA; CELLS, CULTURED; CYCLIC AMP; DEHYDROEPIANDROSTERONE; HUMANS; HYDROCORTISONE; HYPERPLASIA; OXYGEN; PARTIAL PRESSURE; STEROIDS; TUMOR CELLS, CULTURED;

EID: 33644875394     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00337.2005     Document Type: Article

References (27)

1. Breslow MJ, Ball TD, Miller CF, Raff H, and Traystman RJ. Adrenal blood flow and secretory relationships during hypoxia in anesthetized dogs. Am J Physiol Heart Circ Physiol 257: H1458-H1465, 1989.
2. Breslow MJ, Tobin JR, Mandrell TD, Racusen LC, Raff H, and Traystman RJ. Changes in adrenal oxygen consumption during catecholamine secretion in anesthetized dogs. Am J Physiol Heart Circ Physiol 259: H681-H688, 1990.
3. Bruder ED, Nagler AK, and Raff H. Oxygen-dependence of ACTH-stimulated aldosterone and corticosterone synthesis in the rat adrenal cortex: developmental aspects. J Endocrinol 172: 595-604, 2002.
4. Chabre O, Defaye G, and Chambaz EM. Oxygen availability as a regulatory factor of androgen synthesis by adrenocortical cells. Endocrinology 132: 255-260, 1993.
5. Fujita H, Shibata H, Ogata E, and Kojima I. In vitro responsiveness of aldosterone-producing adenoma to angiotensin II, K and ACTH. Endocrinol Jpn 37: 563-570, 1990.
6. Gabbe SG and Villee CA. The effect of hypoxia on progesterone synthesis by placental villi in organ culture. Am J Obstet Gynecol 111: 31-37, 1971.
7. Gandara DR, Lara PN Jr, Goldberg Z, Le QT, Mack PC, Lau DH, and Gumerlock PH. Tirapazamine: prototype for a novel class of therapeutic agents targeting tumor hypoxia. Semin Oncol 29: 102-109, 2002.
8. Grondal S, Grimelius L, Thoren M, and Hamberger B. Basal and ACTH-stimulated cortisol and aldosterone release from adrenocortical adenomas in vitro. Eur J Surg 157: 179-183, 1991.
9. Hanke CJ and Campbell WB. Endothelial cell nitric oxide inhibits aldosterone synthesis in zona glomerulosa cells: modulation by oxygen. Am J Physiol Endocrinol Metab 279: E846-E854, 2000.
10. Hirata Y, Tomita M, Yoshimi H, Kuramochi M, Ito K, and Ikeda M. Effect of synthetic human atrial natriuretic peptide on aldosterone secretion by dispersed aldosterone-producing adenoma cells in vitro. J Clin Endocrinol Metab 61: 677-680, 1985.
11. Marik PE and Zaloga GP. Adrenal insufficiency during septic shock. Crit Care Med 31: 141-145, 2003.
12. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, and Young WF Jr. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 89: 1045-1050, 2004.
13. Naruse M, Obana K, Naruse K, Yamaguchi H, Demurea H, Inagama T, and Shizume K. Atrial natriuretic polypeptide inhibits cortisol secretion as well as aldosterone secretion in vitro from human adrenal tissue. J Clin Endocrinol Metab 64: 10-16, 1987.
14. Orth DN, Kovacs WJ, and DeBold DR. The adrenal cortex. In: Williams Textbook of Endocrinology, edited by Wilson JD and Foster DW. Philadelphia: WB Saunders, 1992.
15. Papanek PE, Jankowski BM, and Raff H. Aldosterone release from adrenal cells is inhibited by hypoxia in vitro during maturation in rabbits. Reprod Fertil Dev 8: 1131-1136, 1996.
16. Raff H. The renin-angiotensin-aldosterone system during hypoxia. In: Response and Adaptation to Hypoxia - Organ to Organelle, edited by Lahiri S, Cherniak N, and Fitzgerald RS. New York: Oxford Univ. Press, 1991, p. 211-222.
17. Raff H. Endocrine adaptation to hypoxia. In: Handbook of Physiology. Environmental Physiology. Bethesda, MD: Am. Physiol. Soc., 1996, sect. 4, vol. II, chapt. 54, p. 1259-1275.
18. Raff H, Ball DL, and Goodfriend TL. Low oxygen selectively inhibits aldosterone secretion from bovine adrenocortical cells in vitro. Am J Physiol Endocrinol Metab 256: E640-E644, 1989.
19. Raff H, Brickner RC, and Jankowski B. The renin-angiotensin-aldosterone system during hypoxia: Is the adrenal an oxygen sensor? In: Hypoxia and Mountain Medicine, edited by Sutton JR, Coates G, and Houston CS. Oxford and New York: Advances in the Biosciences, Pergamon, 1992, vol. 84, p. 42-49.
20. Raff H and Findling JW. Aldosterone control in critically ill patients: ACTH, metoclopramide, and atrial natriuretic peptide. Crit Care Med 18: 915-920, 1990.
21. Rockwell S. Oxygen delivery: implications for the biology and therapy of solid tumors. Oncol Res 9: 383-390, 1997.
22. Steinberg AP, Kilciler M, Abreu SC, Ramani AP, Ng C, Desai MM, Kaouk JH, and Gill IS. Laparoscopic nephron-sparing surgery for two or more ipsilateral renal tumors. Urology 64: 255-258, 2004.
23. Stevens VL, Aw TY, Jones DP, and Lambeth JD. Oxygen dependence of adrenal cortex cholesterol side chain cleavage. J Biol Chem 259: 1174-1179, 1984.
24. Stone HB, Brown JM, Phillips TL, and Sutherland RM. Oxygen in human tumors: correlations between methods of measurement and response to therapy. Radiat Res 136: 422-434, 1993.
25. Stowasser M, Tunny TJ, Klemm SA, and Gordon RD. Cortisol production by aldosterone-producing adenomas in vitro. Clin Exp Pharmacol Physiol 20: 292-295, 1993.
26. Vaupel P, Thews O, and Hoeckel M. Treatment resistance of solid tumors. Med Oncol 18: 243-259, 2001.
27. Wouters BG, Weppler SA, Koritzinsky M, Landuyt W, Nuyts S, Theys J, Chiu RK, and Lambin P. Hypoxia as a target for combined modality treatments. Eur J Cancer 38: 240-257, 2002.